ATI

ATI is executing well on the commercial aerospace and defense upcycle. FY2025 revenue rose 5.2% to $4.59B — its highest since 2012 — with aerospace & defense now ~68% of sales and growing 14% YoY, defense alone +24% in HPMC. The quality of earnings improved across the board: gross margin expanded 140bps to 22.0%, operating income reached $641M, net income grew 9.9% to $404M, diluted EPS rose 11.8% to $2.85, and ROE is a healthy 22.4%. Critically, operating cash flow jumped ~51% to $614M as management attacked working-capital intensity, funding both $281M of capex and $470M of buybacks (6.4M shares, ~3.7% of the count retired) while still repaying $150M of debt. Retained earnings turned firmly positive and the balance sheet is sound (liabilities/equity 1.76x, current debt cut 82.8%).

The problem is price, not the business. At $201.34 the stock trades at 70.6x FY diluted EPS and 6.0x sales for a company earning an 8.8% net margin in an industry management itself repeatedly describes as cyclical. The Risk Factors are blunt: demand fluctuates with commercial aerospace build rates, general industrial markets are 'highly cyclical,' and pricing power is constrained by overcapacity, imports, and raw-material inflation. Cash fell 42% to $417M as buybacks were funded aggressively, leaving less cushion if the cycle turns. A multiple this rich prices in continued double-digit aero growth and margin expansion with essentially no allowance for the cyclicality the company explicitly warns about.